Finance entity
Every one of those 2 sits in a single category, earnings. Freightos is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 1.1 stories per week across a 13-day span. At 5, the average consequence score sits below the same-window beat average of 6.2.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, earnings. Freightos is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 1.1 stories per week across a 13-day span. At 5, the average consequence score sits below the same-window beat average of 6.2. They are less corroborated than the beat average, carrying 2.5 original sources each against 2.7 for the same window. PepGen appears in 2 tracked Finance stories published from February 21, 2026 through March 5, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 836 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering PepGen. Shared-story counts are live from our verified record — not editorial picks.
OmniAb and PepGen reported full-year 2025 results, showcasing the health of the antibody discovery and neuromuscular therapeutics sectors. While OmniAb focuses on platform scalability and royalty streams, PepGen emphasizes clinical execution and cash preservation for its lead candidates.
A trio of high-growth companies across genomics, biotechnology, and digital logistics are set to report quarterly results this Monday. Investors will be closely monitoring GeneDx's path to profitability, PepGen's clinical cash runway, and Freightos's transaction volume growth.
PepGen is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
